ClinicalTrials.Veeva

Menu

Focal Therapy for Localized Prostate Cancer

University of California San Diego logo

University of California San Diego

Status

Enrolling

Conditions

Prostate Cancer

Treatments

Procedure: Focal Therapy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This prospective registry and longitudinal study that is designed to carefully measure details of prostate cancer patients' outcomes with focal therapy. The goal of which is to improve patient care.

Full description

This observational study will serve to collect data from medical record and review questionnaires before and after focal ablation of prostate tissue. All enrolled subjects will have already undergone or scheduled to receive the focal therapy as part of their prostate cancer treatment.

Enrollment

500 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subject has elected or already undergone focal therapy as their standard of care treatment method and declined alternative treatment (active surveillance, radical prostatectomy, and radiation therapy)
  • PSA ≤ 20
  • Ability to complete informed consent form

Exclusion criteria

  • Contraindication to follow-up multi parametric MRI or prostate biopsy
  • Unable to tolerate general or regional anesthesia

Trial design

500 participants in 1 patient group

Focal Therapy
Description:
Subjects who have biopsy-proven adenocarcinoma of the prostate, who have met all study inclusion and exclusion criteria, and have elected to receive or have already received focal therapy as part of their routine prostate cancer treatment, will be invited to participate in this observational registry study.
Treatment:
Procedure: Focal Therapy

Trial contacts and locations

1

Loading...

Central trial contact

Juan Javier-DesLoges, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems